Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma
Por:
Blanes, M, Lorenzo, J, Ribas, P, Jimenez, A, Gonzalez, J, Cejalvo, M, Solano, C, Alegre, A and de la Rubia, J
Publicada:
1 ago 2019
Ahead of Print:
16 mar 2019
Resumen:
Filiaciones:
:
Hematology Service, University Hospital General de Elda, Alicante, Spain
Lorenzo, J:
Hematology Service, University Hospital La Fe, Valencia, Spain
Ribas, P:
Hematology Service, University Hospital Doctor Peset, Valencia, Spain
Jimenez, A:
Hematology Service, University Hospital 12 de Octubre, Madrid, Spain
Gonzalez, J:
Hematology Service, University Hospital Insular de Canarias, Las Palmas, Spain
Cejalvo, M:
Hematology Service, University Hospital Doctor Peset, Valencia, Spain
Solano, C:
Hematology Service, University Hospital Clínico, Valencia, Spain
Alegre, A:
Hematology Service, University Hospital La Princesa, Madrid, Spain
de la Rubia, J:
Hematology Service, University Hospital Doctor Peset, Valencia, Spain.
Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain.
|